Results 231 to 240 of about 21,108 (240)

Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial

Diabetes Care, 2015
Keith Bowering, Shamik Parikh
exaly  

Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes

Diabetes Care, 2013
Marcus Hompesch, David W. Boulton, Ralph DeFronzo   +2 more
exaly  

Dapagliflozine

Nursing, 2021
openaire   +1 more source

Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2

Diabetes Care, 2019
Tal Oron, Marcus Lind, Chantal Mathieu
exaly  

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

Diabetes, Obesity and Metabolism, 2013
Dick de Zeeuw, H J Lambers Heerspink
exaly  

Effect of a high-fat meal on the pharmacokinetics of dapagliflozin, a selective SGLT2 inhibitor, in healthy subjects

Diabetes, Obesity and Metabolism, 2011
Marc Pfister, D W Boulton
exaly  

Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice†

Diabetes, Obesity and Metabolism, 2014
David G Parkes
exaly  

The anti-diabetic drug dapagliflozin induces vasodilation via activation of PKG and Kv channels

Life Sciences, 2018
Won Sun Park, Won-Kyo Jung, Il-Whan Choi
exaly  

Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease

Diabetes, Obesity and Metabolism, 2019
Kunihiro Suzuki, Isao Usui, Yoshimasa Aso   +2 more
exaly  

Dapagliflozin

2013
openaire   +1 more source